Radioembolization Y-90 Microsphere Dosimetry: Understanding…

What Radioembolization is

Radioembolization is a form of internal radiation therapy used to treat liver cancer. In this procedure, tiny beads containing the radioactive isotope Yttrium-90 (Y-90) are delivered directly into the hepatic arteries feeding the tumor. These microspheres release beta particles over time, destroying the cancer cells while minimizing exposure to surrounding healthy tissues.

The technique combines the precision of targeted radiation with the minimally invasive nature of embolization, making it a valuable tool in oncology.

Dosimetry and Its Importance

Dosimetry is crucial for ensuring that the radioembolization treatment delivers sufficient radiation to kill cancer cells without causing excessive damage to healthy tissues. The Y-90 microsphere dosimetry involves calculating the absorbed dose of radiation in both the tumor and adjacent normal liver tissue. This calculation helps in tailoring the treatment plan to achieve optimal therapeutic outcomes.

Accurate dosimetry is essential for minimizing side effects, such as liver toxicity, while maximizing the effectiveness of the therapy.

live demo · related simulation● LIVE

How Dosimetry Works

Dosimetry in radioembolization involves several steps. First, the size and location of the tumor are determined using imaging techniques like CT or MRI. The number and size of Y-90 microspheres required to deliver a therapeutic dose are then calculated based on these images. This calculation takes into account factors such as the blood flow in the liver, the distribution of the microspheres within the tumor, and their radioactive decay.

The dosimetry process also involves monitoring the radiation levels over time to ensure that the treatment is effective and safe.

Real-World Applications

Radioembolization with Y-90 microspheres has been successfully used in treating various types of liver tumors, including hepatocellular carcinoma (HCC) and metastatic cancers. The technique is particularly beneficial for patients who are not candidates for surgical resection or other forms of external beam radiation therapy.

Studies have shown that radioembolization can significantly improve survival rates and quality of life for these patients.

Frequently asked questions

How does the Y-90 microsphere deliver radiation to cancer cells?

The Y-90 microspheres are injected into the hepatic arteries supplying blood to the tumor. The beads become lodged in small blood vessels within the tumor, where they release beta particles that destroy cancer cells through direct irradiation and indirect effects on nearby tissues.

What are the potential side effects of radioembolization?

Common side effects include liver toxicity, fatigue, nausea, and pain. More severe complications can occur but are less frequent, such as infection or bleeding in the treated area.

How is the effectiveness of the treatment monitored after radioembolization?

The effectiveness of the treatment is monitored using imaging techniques like CT scans or MRI to assess tumor response and liver function. Blood tests may also be performed to check for signs of liver toxicity.

Can Y-90 microsphere therapy be used in all types of liver tumors?

Radioembolization with Y-90 microspheres is primarily used for treating hepatocellular carcinoma and metastatic cancers. It may not be suitable for certain types of tumors or patients with specific medical conditions.

Try it live

Everything above runs in your browser — open Radioembolization Y-90 Microsphere Dosimetry Simulator and change the parameters while it is running. Nothing is installed, nothing is uploaded, the whole model lives in one tab.

▶ Open Radioembolization Y-90 Microsphere Dosimetry Simulator simulation

Radioembolization Y-90 Microsphere Dosimetry: Understanding Radiation Distribution in Liver Tumors